We are pleased to share that we exhibited at the 8th RSC-BMCS Fragment-based Drug Discovery Meeting held on 27th-29th March 2022, at The Churchill College, Cambridge, UK. Claudio Dagostin represented the o2h discovery in the event!

The aim of the 8th RSC-BMCS Fragment-based Drug Discovery meeting is regularly attended by scientists including chemists, biophysicists, structural biologists, etc., with the aim to focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. 

o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.

For more details about the conference, please visit – https://lnkd.in/gBkcvrk2